Acute effects of breaking up prolonged sitting on fatigue and cognition: a pilot study. by Wennberg, Patrik et al.
Acute effects of breaking up prolonged
sitting on fatigue and cognition: a pilot
study
Patrik Wennberg,1 Carl-Johan Boraxbekk,2 Michael Wheeler,3,4 Bethany Howard,3,5
Paddy C Dempsey,3,5 Gavin Lambert,3,5 Nina Eikelis,3 Robyn Larsen,3
Parneet Sethi,3 Jessica Occleston,3 Jenny Hernestål-Boman,1 Kathryn A Ellis,6
Neville Owen,3,5,7,8 David W Dunstan3,4,5,7,8,9,10,11
To cite: Wennberg P,
Boraxbekk C-J, Wheeler M,
et al. Acute effects of
breaking up prolonged sitting
on fatigue and cognition: a
pilot study. BMJ Open
2016;6:e009630.
doi:10.1136/bmjopen-2015-
009630
▸ Prepublication history and
additional material is
available. To view please visit
the journal (http://dx.doi.org/
10.1136/bmjopen-2015-
009630).
Received 4 August 2015
Revised 8 December 2015
Accepted 22 December 2015
For numbered affiliations see
end of article.
Correspondence to
Dr Patrik Wennberg;
patrik.wennberg@umu.se
ABSTRACT
Objectives: To compare the acute effects of
uninterrupted sitting with sitting interrupted by brief
bouts of light-intensity walking on self-reported fatigue,
cognition, neuroendocrine biomarkers and
cardiometabolic risk markers in overweight/obese adults.
Design: Randomised two-condition crossover trial.
Setting: Laboratory study conducted in Melbourne,
Australia.
Participants: 19 overweight/obese adults
(45–75 years).
Interventions: After an initial 2 h period seated,
participants consumed a meal-replacement beverage and
completed (on 2 days separated by a 6-day washout
period) each condition over the next 5 h: uninterrupted
sitting (sedentary condition) or sitting with 3 min bouts
of light-intensity walking every 30 min (active condition).
Primary outcome measures: Self-reported fatigue,
executive function and episodic memory at 0 h, 4 h and
7 h.
Secondary outcome measures: Neuroendocrine
biomarkers and cardiometabolic risk markers (blood
collections at 0 h, 4 h and 7 h, blood pressure and heart
rate measured hourly and interstitial glucose measured
using a continuous glucose monitoring system).
Results: During the active condition, fatigue levels were
lower at 4 h (−13.32 (95% CI −23.48 to −3.16)) and at
7 h (−10.73 (95% CI −20.89 to −0.58)) compared to
the sedentary condition. Heart rate was higher at 4 h
(4.47 (95% CI 8.37 to 0.58)) and at 7 h (4.32 (95% CI
8.21 to 0.42)) during the active condition compared to
the sedentary condition. There were no significant
differences between conditions by time for other
variables. In the sedentary condition, changes in fatigue
scores over time correlated with a decrease in heart rate
and plasma dihydroxyphenylalanine (DOPA) and an
increase in plasma dihydroxyphenylglycol (DHPG).
Conclusions: Interrupting prolonged sitting with light-
intensity walking breaks may be an effective fatigue
countermeasure acutely. Fatigue levels corresponded
with the heart rate and neuroendocrine biomarker
changes in uninterrupted sitting in this pilot study.
Further research is needed to identify potential
implications, particularly for the occupational health
context.
Trial registration number: ACTRN12613000137796;
Results.
INTRODUCTION
There is accumulating evidence on the nega-
tive health consequences of prolonged
sitting. Previous experimental studies have
demonstrated that uninterrupted sitting is
deleteriously associated with metabolic para-
meters,1 2 blood pressure3 and markers of
haemostasis4 when compared to sitting that
is interrupted with short bouts of physical
activity. A recent experimental trial utilising a
7 h ‘whole working day’ model found that in
overweight and obese adults, regularly inter-
rupting sitting time with short bouts of either
light-intensity or moderate-intensity walking
lowered postprandial glucose and insulin
concentrations when compared with pro-
longed sitting.1 Although glucose ingestion
has been suggested to acutely improve
memory and cognitive function,5 meals that
trigger postprandial hyperglycaemia have
been associated with a decline in cognitive
function relative to meals that cause a more
Strengths and limitations of this study
▪ This is the first experimental study to compare
the acute effects of uninterrupted sitting on sub-
jective fatigue and cognitive functioning with
sitting interrupted every 30 min with light-
intensity walking in a 7 h ‘whole working day’
model.
▪ A randomised crossover study design was used.
▪ Given that this is a pilot study, the sample size
may have limited the ability to detect an effect
from breaking up sitting in several of the
outcome measures.
▪ The longer term relevance of acute effects of
breaking up prolonged sitting is uncertain.
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gradual rise in blood glucose concentrations.6 The emer-
ging evidence relating changes in postprandial glucose
to changes in cognitive function provides a rationale to
investigate whether breaking up prolonged sitting with
light-intensity physical activity may also be relevant for
cognitive performance.
Aside from the metabolic beneﬁts, physical activity
may mediate several putative pathways involved in
general mental fatigue and cognition. These include
increased cerebral blood ﬂow7 and expression of neuro-
trophins such as brain-derived neurotrophic factor
(BDNF),8 which have been linked to both acute neur-
onal activation and long-term functional and structural
changes in the brain.9 During physical activity, particu-
larly of higher intensities, there is a release of epineph-
rine and norepinephrine from the adrenal medulla.
Also, peripheral catecholamine release has a direct
effect on synthesis and release of norepinephrine in the
brain via activation of adrenoreceptors on vagal afferent
nerves10 that may increase alertness and facilitate cogni-
tion. Some sedentary behaviours, such as TV viewing,
have been linked to adverse long-term effects such as
detrimental cognitive development in early childhood11
and poorer cognitive function in older adults,12 but the
mediating pathways are not well understood.
The possible inﬂuence of prolonged sitting on cogni-
tion is of great potential importance for work productiv-
ity and cognitive health, especially among ofﬁce workers
who are particularly vulnerable to prolonged uninter-
rupted sedentary behaviour.13 In previous research,
ofﬁce workers have reported reduced fatigue across the
day with the use of sit-to-stand desks when compared to
seated work,14 15 but also self-perceived hampered con-
centration and focus when sitting and standing work
were combined.14 Given this preliminary evidence, and
from a physiological standpoint, we hypothesise that the
pattern of intermittent short bouts of physical activity
leading to reduced prolonged sedentary states may
confer greater beneﬁt on fatigue and cognitive perform-
ance than uninterrupted sitting. We examined, in a 7 h
‘whole working day’ model, the acute effects of uninter-
rupted sitting on subjective fatigue and cognitive func-
tioning (executive functions and episodic memory),
compared with sitting interrupted every 30 min with
light-intensity walking. The study had an explorative
approach and a small sample size and was conducted as
an evaluation of technical procedures and logistic feasi-
bility of a full-scale study (clinical trial registration
ACTRN12614000737639).
METHODS
Study design
The study was a laboratory-based randomised crossover
trial with two experimental conditions separated by a
6-day washout period. All participants provided signed
informed consent.
Participants
Participants were recruited from the general community
between May and August 2013 through the use of study
ﬂiers and posters or were contacted on the basis of their
previously registered expression of interest in future
studies (see online supplementary ﬁgure). Eligible parti-
cipants were aged 45–75 years with a body mass index
(BMI) ≥25 kg/m2 but <40 kg/m2, who reported sitting
>5 h a day and were not engaged in regular
moderate-to-vigorous intensity physical activity (MVPA;
≥150 min/week for >3 months). Exclusion criteria
included those who were: non-English speaking, preg-
nant, currently smoking, diagnosed with diabetes,
reported to have cognitive or physical problems that may
limit the ability to perform the activity bouts or complete
the computer-based cognitive test programme, currently
using any of the following medications: glucose-lowering,
lipid-lowering, antidepressant or oral cortisone medica-
tion. Consistent with a previous trial with a similar experi-
mental design,1 19 participants were recruited.
Randomisation
Participants were randomised to one of two possible
trial-condition orders using ﬁxed block sizes for men
and women. The computer-generated randomisation list
and randomisation envelopes were prepared and kept
by a third party. Research staff opened randomisation
envelopes once informed consent was obtained.
Pre-experimental procedure
Screening and familiarisation
Following telephone screening, participants attended an
assessment and familiarisation visit at the research
laboratory. During this visit, they underwent training on
the cognitive test battery and were given the opportunity
to ask questions and were allowed unlimited time to
complete practice tests to ensure sufﬁcient understand-
ing of each task. They were then familiarised with
walking on the motorised treadmill on a level incline.
Diet and physical activity
To control and account for any diet-induced variability
in study outcomes, participants were provided with stan-
dardised meal packs for consumption on the evening
prior to each experimental condition. The meal packs
(consisting of a drink, snack and a commercially avail-
able microwave meal) were individualised to meet
33.3% of daily estimated energy requirements using the
Schoﬁeld equation16 with a 1.5 physical activity factor
and a target macronutrient proﬁle of 12–15% energy
from protein, 55–58% energy from carbohydrate and
29–31% energy from fat. To minimise the potential
carryover effects of physical activity, participants were
instructed to avoid any moderate and/or vigorous phys-
ical activity for at least 48 h prior to each experimental
condition. Sitting time and MVPA were assessed with an
accelerometer, Actigraph GT3X+ (ActiGraph LLC,
Pensacola, Florida, USA), which was worn on the hip
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during waking hours. The participants wore the acceler-
ometer starting from the familiarisation visit until the
end of the second experimental day. Wear time and
activity type, duration and intensity undertaken during
any non-wear periods were recorded in activity diaries.
Accelerometer data were downloaded using ActiLife
6.5.4 software and summarised using SAS V.9.4 for each
of the habitual days prior to the condition. Non-wear
periods were deleted for analyses; these were periods
with at least 60 min of zero counts per minute (cpm),
allowing for up to two consecutive, 1 min interruptions
(count values between 1–49 cpm) per non-wear
period.17 Activity counts were categorised as sedentary
(<100 cpm; predominantly sitting),18 light-intensity activ-
ity (100–1951 cpm; typically gentle walking),19 or MVPA
(≥1952 cpm; typically at least brisk walking).19 Average
of sitting time and MVPA were calculated for each indi-
vidual across valid days (days where the monitor was
worn for at least 600 min).
Experimental procedure
The study protocol is shown in ﬁgure 1. After having
fasted overnight, participants arrived at the laboratory
between 7:00 and 8:00 hours. In both conditions, partici-
pants remained seated for the initial 2 h to ensure that a
sedentary status was achieved prior to the consumption
of a mixed meal. The mixed meal was provided as a
200 mL drink containing 50 g fat (Calogen; Nutricia,
Australia) and 75 g carbohydrate (100% maltodextrin
powder; Natural Health, Australia). This meal was
chosen to be consistent with previous work that revealed
differences in postprandial glucose and insulin levels
with prolonged sitting when compared with to an
equivalent duration of sitting that is interrupted with
short bouts of light-intensity walking.1 A small snack
(Oatmeal biscuits; Paradise, Australia) was also provided
to participants at 5 h to circumvent any unwanted effects
from postprandial hypoglycaemia.
After the mixed meal, participants followed their
respective trial condition protocols for the following 5 h
under the direct supervision of research staff. In the sed-
entary condition, participants remained seated during
the experimental period, only rising from the chair to
visit the toilet (on the same ﬂoor, approximately 15 m
from the chair). During the sedentary condition, 14 par-
ticipants visited the toilet (8 participants on one occa-
sion, 3 participants on two occasions, 2 participants on
three occasions and 1 participant on four occasions)
compared to the active condition where 8 participants
visited the toilet only once.
In the active condition, participants rose from the
seated position every 30 min throughout the experimen-
tal period and completed a 3 min bout of light-intensity
walking on a motorised treadmill (Nautilus T916) at a
level incline (0 gradient) at 3.2 km/h. They then
returned to the seated position. This procedure was
undertaken on 10 occasions, providing a total of 30 min
of light-intensity activity. Previous research has shown
that a 2 min bout of light-intensity walking every 20 min
lowered postprandial glucose and insulin concentra-
tions,1 but the intervals were expanded in the current
study to enable a complete session of fatigue and cogni-
tive assessments during a single bout of sitting.
At 0 h, 4 h and 7 h, participants completed the visual
analogue scale for fatigue (VAS-F)20 directly followed by
the cognitive test battery (described under ‘Cognitive
assessment’ below) (total time: 26±1 min). The cognitive
tests were conducted using E-prime 2.0 (Psychology
Software Tools Inc) on a Toshiba Satellite Pro C650
laptop computer with a 1366×768, 15.6 inch screen in a
seated position. Throughout both conditions, partici-
pants read books, magazines or newspapers, watched
television or DVDs or worked on a laptop computer.
However, participants were instructed to limit the
amount of interactive multimedia or problem-solving
tasks to avoid impact on the cognitive testing. Blood
Figure 1 Study protocol.
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collections, fatigue and cognitive tests (in that order)
were undertaken at 0 h, 4 h and 7 h.
Fatigue assessment
VAS for fatigue
A VAS to evaluate fatigue severity (VAS-F) was used
during the experimental days. The VAS-F questionnaire
consisted of 18 items related to the subjective experi-
ence of fatigue and energy and has shown high reliabil-
ity (Cronbach’s α 0.91–0.96), sensitivity for changes in
fatigue over a day, and compares favourably with the
Stanford Sleepiness Scale and the Proﬁle of Mood States
in healthy participants.20 Each item asks participants to
mark with a single vertical dash, representing how they
currently feel, on a continuous horizontal line that
extends between two extremes, for example from ‘not at
all tired’ to ‘extremely tired’.
Cognitive assessment
A battery of cognitive tests covering functions including
episodic memory, inhibition and updating were used.
The focus on central executive tasks was chosen on the
basis of previously described larger effect size for higher-
order cognitive tasks compared to less complex tasks.21 22
To test episodic memory function, a face-name associ-
ation test was used.23 Participants were instructed to
remember a ﬁctional name associated with an unknown
face. During retrieval, they were presented with the previ-
ously viewed faces together with three letters. The task
was to indicate which of the three letters corresponded to
the ﬁrst letter of the name that was associated with the
face. To test the executive function of inhibition, two tests
were used, the Eriksen ﬂanker task24 and a modiﬁed
Stroop colour-word task.25 In the Eriksen ﬂanker task,
the participants indicated the direction of the middle
arrow in either congruent (>>>>>) or incongruent
(>><>>) stimuli by pressing a button as fast and as accur-
ately as possible. In the Stroop test, participants were
asked to indicate the colour a colour-word was written in,
for example, ‘blue’ written in the colour blue, respond-
ing as fast and as accurately as possible.
The executive function updating was also tested using
two tests: n-back26 and letter memory.27 In n-back, the
participants were asked to indicate whether each
number (1–9) in a list matched a number occurring
one, two or three numbers back. Accuracy and response
time were used as dependent measures. In letter
memory, they viewed lists consisting of serially presented
letters (A–D, 2 s per letter). They did not know the
length of each list. When the list ended, they were asked
to recall the last four presented letters in the correct
order as fast and as accurately as possible. A cognitive
composite score (Z-score transformed) was derived from
the ﬁve cognitive subtests.
Continuous glucose monitoring
Glucose concentrations were recorded using an IPro2
(Medtronic) Continuous Glucose Monitoring System
(CGMS)28 29 during both experimental conditions. The
CGMS sensor was inserted under the skin in the lower
back, lateral to the medioclavicular line between the
iliac crest and the lowest rib, and measured interstitial
glucose concentrations every 5 min. Capillary ﬁnger-
pricks (Optium Xceed) at 0 h, 1 h and 4 h were used for
calibration in accordance with the manufacturer’s
instructions. The total area under the glycaemic
response curve (total AUC) and the net incremental
AUC (net iAUC), which includes all incremental area
below the curve, including the area below the fasting
concentration, was derived from the CGMS
measurements.
Plasma analysis
Fasting and postprandial blood samples were collected
from a venous cannula inserted into the lower arm.
Blood was transferred in EDTA tubes for BDNF, insulin,
interleukin 6, cortisol and in Glutathione (GSH)/
Ethylene Glycol Tetraacetic Acid (EGTA) tubes for ana-
lysis of catechols after at least 10 min of seated rest fol-
lowing the cannulation. Samples were immediately put
on ice, then centrifuged (1800 rpm for 20 min at 4°C)
within 30 min of collection, and plasma was stored at
−80°C for later analysis. To avoid intra-assay variability,
analyses of biochemical markers from the EDTA plasma
were conducted in a single batch after the study.
Catechols, however, were analysed within 2 months in
three batches to minimise the risk of degradation from
long-term storage. Plasma catechols were determined by
high-performance liquid chromatography with coulo-
metric detection, following extraction from plasma using
alumina adsorption.30
Blood pressure and heart rate measurements
Blood pressure and heart rate were measured hourly
using an automated oscillometric blood pressure
monitor (Digital Automatic Blood Pressure Monitor
HEM-907, Omron, Kyoto, Japan) as the average of three
single measurements. The measurements were taken at
5 min before each walking bout in a seated upright pos-
ition on the arm contralateral to the arm with the intra-
venous cannula.
Statistical analysis
Generalised linear mixed models (GLMMs) with a
single random intercept (participant) were used to
examine the differential effects of the experimental con-
ditions in variables measured continuously (interstitial
glucose), hourly and at 0 h, 4 h and 7 h. All analyses
were adjusted for time and order effects and interstitial
glucose changes were also adjusted for capillary fasting
glucose concentration and BMI. Temporal changes
between conditions were also assessed by including a
condition-time interaction term. Pearson’s pairwise cor-
relation tests were used to assess the relationship of
fatigue to plasma markers. A probability level of 0.05 was
adopted. All statistical analyses were performed using
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Stata V.12 for Windows (StataCorp LP). Data are
reported as mean (±SD) in the text and tables and as
estimated marginal means±SEM in the ﬁgures unless
otherwise indicated.
RESULTS
All 19 participants (mean age 59.7±8.1 years; 10 men/9
women) completed both trial conditions and were
included in the analyses. Participant characteristics are
shown in table 1.
According to the accelerometer data, participants
engaged in a modest amount of daily MVPA during the
washout period. Levels of MVPA in the 48 h prior to
each experimental condition did not differ signiﬁcantly
(36.29±29.20 min/day before the sedentary condition vs
30.18±42.16 min/day before the active condition;
p=0.607).
The mean rating of perceived exertion (RPE),
assessed by the Borg RPE scale,31 for the walking bouts
was 9.1±2.0 (9 corresponds with ‘Very light’ on the Borg
RPE scale). Within-condition and between-condition
responses for the fatigue score, cognitive scores and bio-
markers at 0 h, 4 h and 7 h are presented in tables 2 and
3, respectively. An effect of time was seen for fatigue (at
4 h, p=0.008; at 7 h, p=0.010), cognitive composite score
(at 7 h, p=0.033) and heart rate (at 4 h, p<0.001; at 7 h,
p<0.001) in both conditions combined. During the
active condition, fatigue levels were lower at 4 h (−13.32
(95% CI −23.48 to −3.16)) and at 7 h (−10.73 (95% CI
−20.89 to −0.58)) compared to the sedentary condition
(see ﬁgure 2). Heart rate was higher at 4 h (4.47 (95%
CI 8.37 to 0.58)) and at 7 h (4.32 (95% CI 8.21 to 0.42))
during the active condition compared to the sedentary
condition. A trend (p=0.077) for improvement in the
episodic memory test was observed in the active condi-
tion compared to the sedentary condition. No statistic-
ally signiﬁcant differences were seen for any of the other
measured variables, including the individual executive
function tests (results are only shown for the composite
scores), interstitial glucose total AUC (p=0.48) and net
iAUC (p=0.14). The changes in fatigue score over time
correlated with a decrease in heart rate (0–4 h: rs=−0.60,
p=0.007) and plasma level of DOPA (0–4 h: rs=−0.59,
p=0.009) and an increase in plasma level of DHPG (0–
4 h: rs=0.73, p<0.001; 0–7 h: rs=0.47, p=0.040) in the sed-
entary condition (but not in the active condition).
DISCUSSION
Increases in fatigue levels observed during uninter-
rupted sitting were attenuated signiﬁcantly by intermit-
tent light-intensity walking. A non-signiﬁcant trend for
an improvement in cognitive performance with light-
intensity walking breaks was observed. The difference in
fatigue between the two conditions was observed after
4 h and, interestingly, persisted after 7 h (even though
stabilisation in fatigue score was seen between 4 h and
7 h in the sedentary condition). The increase in fatigue
during uninterrupted sitting correlated with a decrease
in heart rate and changes in plasma levels of catechols
(acute increase of DHPG and a decrease of DOPA). As a
comparison, the magnitude of change in fatigue score
from 0 h to 4 h during uninterrupted sitting corre-
sponds to approximately 40% of the difference in
Table 1 Characteristics of the 19 participants in the study
(10 men and 9 women)
BMI (kg/m2) 31.5 (4.7)
Waist circumference (cm) 105.2 (12.4)
Completed university degree* 78.9
Taking antihypertensive medication* 47.4
Habitual moderate-to-vigorous physical
activity (min/day)†
35.80 (30.86)
Habitual sitting time (h/day)† 9.82 (2.19)
Sleep time (h/night)* 7.4 (0.8)
Data are % or mean (SD).
*Assessed using self-reports.
†Assessed using activity monitors during the washout period
between the two experimental days.
BMI, body mass index.
Table 2 Within-condition responses for the fatigue and cognitive scores at 0, 4 and 7 h
Time (h)
Score Condition N 0 4 7 p Value*
Fatigue score Active 19 37.9 (18.19) 34.3 (17.28) 36.6 (19.09)
Sedentary 19 37.4 (16.0) 47.1 (18.84) 46.8 (18.42)
0.024
Cognitive composite Active 19 0.018 (0.52) 0.080 (0.45) 0.273 (0.28)
score Sedentary 19 −0.016 (0.50) 0.058 (0.33) 0.156 (0.41) 0.669
Cognitive subtests
Executive functions Active 19 −0.002 (0.49) 0.127 (0.43) 0.171 (0.30)
composite score Sedentary 19 0.003 (0.45) 0.079 (0.36) 0.154 (0.39) 0.886
Episodic memory score Active 19 68.9 (10.70) 64.5 (13.84) 78.5 (11.6)
Sedentary 19 65.4 (14.77) 66.2 (11.61) 69.3 (11.8) 0.077
Bold typeface indicates significance at p<0.05.
*p Values for difference in temporal changes by condition.
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fatigue score recorded before and after one night’s sleep
in a study of 75 healthy individuals aged 18–55 years.20
Previous research on the relationship between seden-
tary behaviour and fatigue in adults is scarce. Ellingson
and colleagues32 reported that women who were cate-
gorised as being insufﬁciently active (<150 min/week),
but who also spent less time sedentary (≤1 h/day, mea-
sured by accelerometer), had signiﬁcantly lower levels of
fatigue compared with their more sedentary peers. Our
ﬁndings are consistent with those of Thorp et al,14 who
observed signiﬁcant attenuations in fatigue levels in
ofﬁce workers transitioning from a seated to a standing
work posture every 30 min across the workday, relative to
seated work. These ﬁndings add to the existing literature
by providing initial experimental evidence that the rela-
tionship of prolonged uninterrupted sitting and fatigue
may be causal and by examining the effect of short inter-
mittent light-walking breaks on increased fatigue.
Fatigue is a multifaceted phenomenon. Acute fatigue
can be viewed as a normal and protective mechanism to
physical and/or mental exertion, which usually
decreases as the exertion recedes. In contrast, persistent
fatigue is associated with several medical and psychiatric
illnesses as well as impaired cognitive performance33
and is one of the most common symptoms in commu-
nity and primary care settings.34 The underlying neuro-
biological mechanisms that may be responsible for the
increased fatigue from prolonged sitting and attenuated
fatigue from intermittent walking breaks observed in
this study are unclear. However, studies in individuals
with chronic fatigue have found several alterations and/
or dysfunctions in nervous and endocrine systems,35
such as impaired autonomic nervous functions.36
Interestingly, studies have also found autonomic nervous
alterations (detected via electrocardiography) associated
with daily levels of fatigue in healthy individuals after a
30 min fatigue-inducing mental task session.37
The increased fatigue observed during uninterrupted
sitting corresponded with a lower heart rate, decreased
plasma level of DOPA (a precursor of the catechola-
mines dopamine, epinephrine and norepinephrine)
and increased plasma level of DHPG (a deaminated
metabolite of norepinephrine). The changes in heart
rate and plasma levels of these compounds may reﬂect
alterations in the sympathetic nervous system,38 although
more precise measures of sympathetic nervous activity
should be used in order to clarify this issue. Thus, a
potential contributing mechanism through which inter-
mittent walking breaks attenuated increased fatigue may
relate to the maintenance of a balanced regulation of
the autonomic nervous system activity. In addition,
walking breaks may also counteract fatigue by direct
effects on the central nervous system, in which the
increased heart rate may serve to increase the delivery of
glucose to active domains in the brain.39 Functional neu-
roimaging studies have suggested that the basal ganglia
(midbrain) and regions interacting with the basal
ganglia play key roles in fatigue both in fatigued and
healthy individuals.40 The use of these techniques in
future studies has the potential to provide signiﬁcant
advances in understanding whether similar brain
mechanisms may also mediate the effect of intermittent
walking breaks observed in this study.
In contrast to previous research that has used higher
break frequencies,1 the 3 min walking breaks performed
twice an hour in this study did not induce a signiﬁcant
reduction in postprandial glucose levels, indicating that a
greater/more regular stimulus may be required to reduce
postprandial glucose in the studied population. However,
we cannot exclude that the difference in glucose response
compared to the previous trial may to some extent relate
to differences between interstitial glucose and plasma
glucose (which was measured in the previous trial).
Comparisons between the two methods have revealed a
time lag in interstitial glucose of 10–20 min.41 This time
lag may increase when there is a rapid rise in the plasma
glucose41 and decrease during physical activity due to
activity-induced augmented blood ﬂow42 and may explain
why a more rapid increase in postprandial interstitial
glucose was observed in the active condition compared to
the sedentary condition in the current trial.
In many countries, increasing time is spent seden-
tary43 and there is a high prevalence of persistent
fatigue.44 We examined the effects of light-intensity
walking breaks on acute fatigue and whether these
results may have implications for persistent fatigue is
uncertain. In the prolonged uninterrupted sitting condi-
tion, the natural behavioural response to acute fatigue—
rest—did not seem to reduce the fatigue. Consequently,
it could be speculated that uninterrupted sitting may
potentially lead to a vicious cycle of fatigue and further
sedentary behaviour. Indeed, emerging research has
found an association between time spent sedentary and
poor sleep efﬁciency,45 which in turn may lead to
increased fatigue during waking hours.46 Intermittent
Figure 2 Total fatigue score (estimated marginal means) at
0, 4 and 7 h for sedentary and active conditions.
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Table 3 Within-condition responses for biomarkers at 0, 4 and 7 h
Time (h)
Marker Condition 0 N 4 N 7 N p Value*
Heart rate (bpm) Active 64.7 (8.1) 19 71.8 (10.0) 19 71.6 (11.2) 19
Sedentary 63.5 (8.6) 19 66.2 (9.4) 19 66.1 (9.7) 19
0.038
Systolic blood Active 119.5 (10.3) 19 117.5 (11.9) 19 117.5 (11.1) 19
pressure (mm Hg) Sedentary 119.9 (12.7) 19 117.5 (12.7) 19 119.7 (12.9) 19
0.801
Diastolic blood Active 76.1 (7.9) 19 74.2 (9.3) 19 75.3 (7.2) 19
pressure (mm Hg) Sedentary 77.9 (8.6) 19 72.1 (9.6) 19 74.8 (8.8) 19
0.223
Insulin (µU/mL) Active 21.7 (9.2) 18 105 (48.54) 19 17.8 (6.57) 18
Sedentary 20.9 (7.84) 19 96.4 (51.76) 19 19.2 (6.52) 19
0.679
IL-6 (pg/mL) Active 0.95 (0.93) 18 1.32 (0.85) 19 1.92 (1.42) 18
Sedentary 0.94 (0.7) 19 1.21 (0.51) 19 1.34 (0.79) 19
0.123
Cortisol (pg/mL) Active 3452 (3038) 18 1512 (1226) 19 1364 (737) 18
Sedentary 3618 (5472) 19 1651 (1085) 19 2653 (3617) 19
0.611
BDNF (pg/mL) Active 14 905 (8324) 15 15 201 (8628) 16 12 605 (7603) 14
Sedentary 14 226 (6852) 16 13 098 (6854) 15 14 180 (7172) 15
0.184
Catechols
Norepinephrine (pg/mL) Active 427 (220) 18 475 (238) 18 440 (195) 19
Sedentary 375 (192) 18 466 (281) 17 473 (250) 18
0.177
DHPG (pg/mL) Active 1244 (292) 18 1259 (307) 18 1276 (298) 19
Sedentary 1243 (245) 18 1338 (381) 17 1349 (329) 18
0.447
Epinephrine (pg/mL) Active 36.6 (48.35) 17 109.1 (226.7) 17 171.2 (274.89) 18
Sedentary 44.4 (54.31) 18 118.7 (355.09) 17 69.8 (99.55) 18
0.198
DOPA (pg/mL) Active 1884 (497) 18 1616 (455) 18 1862 (557) 19
Sedentary 1919 (505) 18 1739 (476) 17 2051 (588) 18
0.676
Dopamine (pg/mL) Active 23.7 (26.31) 18 63 (158.12) 18 42.4 (75.24) 19
Sedentary 49.6 (134.01) 18 39.6 (81.37) 17 61.2 (190.59) 18
0.234
DHPG/norepinephrine Active 4.0 (1.78) 18 3.4 (1.28) 17 3.3 (1.34) 18
Sedentary 3.4 (1.46) 18 3.0 (1.01) 18 3.2 (1.15) 19
0.434
*p Values for difference in temporal changes by condition.
Bold typeface indicates significance at p<0.05.
BDNF, brain-derived neurotrophic factor; DHPG, dihydroxyphenylglycol; DOPA, dihydroxyphenylalanine; IL-6, interleukin 6.
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light-intensity walking breaks may be a feasible way to
reduce fatigue, especially for individuals with low uptake
of MVPA, but the role for walking breaks in the preven-
tion of persistent fatigue needs to be examined in long-
term interventions.
This is the ﬁrst experimental study to examine the
impact of walking breaks on cognition under conditions
that might correspond to a typical sedentary ofﬁce or
domestic day. The effect on fatigue was not translated
into a statistically signiﬁcant effect on cognitive perform-
ance, contrary to what could be expected from previous
research on fatigue and cognition.47 There are several
possible explanations for the lack of effect on cognition.
First, the cognitive effect from repeated 3 min bouts of
light-intensity physical activity may be too weak to be
detected with our sample size. The optimal intensity of
the physical activity for cognitive effects is still under
debate. For example, the inverted U-hypothesis suggests
that moderate intensity physical activity yields the largest
effect while ‘drive’ theories predict that vigorous inten-
sity will be most beneﬁcial.21 48 A meta-analysis indicated
that when performed directly after the physical activity,
lighter (very light, light and moderate) activity is more
beneﬁcial, but vigorous intensity is necessary for effects
to be maximised if there is a delay between the physical
activity and the cognitive test.21 Second, it is most likely
that reduced fatigue over time may also lead to
improved cognitive functioning; however, this needs to
be evaluated in longitudinal studies. Third, the cognitive
score improved over the day in both conditions, indicat-
ing a practice effect, a common problem in cognitive
studies with repeated assessment which may have dis-
torted the validity of performance outcomes. Potentially,
the cognitive effect from walking breaks may also be
moderated by age, ﬁtness level, educational level and
the activity performed between tests (doing strict ofﬁce
work or leisure activities such as reading, watching
television).
There are several limitations to the study. First, given
that this is a pilot study, it was most likely underpowered
to detect an effect in cognitive performance (as well as
several of the potential mediators). Second, we studied
acute effects, and thus any long-term effects of walking
breaks cannot be evaluated on the basis of the results in
the study. Third, our objective assessments indicated that
the participants on average were engaged in MVPA
>30 min/day, which may have dampened the effect of
prolonged sitting during the trial. Finally, we did not
investigate whether the effects on fatigue and cognition
may be moderated by participant characteristics. We
suggest that future studies should: (1) include a larger
sample size, (2) conduct repeated cognitive training ses-
sions before the experiment to minimise the practice
effect, (3) include a higher frequency of regular blood
collection time points to enable more robust analyses of
changes over time and, (4) apply functional neuroima-
ging techniques to increase the knowledge on neuro-
physiological mechanisms for the relationships between
prolonged sitting, light-walking breaks, fatigue and
cognition.
In conclusion, intermittent light-walking breaks resulted
in an attenuation of fatigue levels during uninterrupted
sitting; however, the difference in fatigue did not translate
into signiﬁcantly improved cognitive performance. Our
ﬁndings provide further support to the suggestion that
the relationship between sedentary behaviour and fatigue
may be causal and that light-intensity walking breaks may
counteract increased fatigue. Although this study only
examined short-term effects, there may be longer term
relevance and implications for sedentary behaviour, par-
ticularly among ofﬁce workers and others with highly sed-
entary occupations. Thus, the role that reduced sedentary
behaviour and walking breaks may play in the prevention
and/or treatment of fatigue warrants further investigation
in a full-scale study. Considering the current high preva-
lence of persistent fatigue in the general population,
reductions in sedentary time may have considerable rele-
vance from a public health perspective.
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